483
Chartwell Pharmaceuticals LLCFDA 483 - Chartwell Pharmaceuticals LLC - December 19, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Chartwell Pharmaceuticals LLC in Congers, NY, revealed significant deficiencies in manufacturing and quality control. The firm failed to validate numerous manufacturing and packaging processes, lacked proper equipment qualification and cleaning validation, and exhibited issues with cross-contamination control and master batch records. These findings indicate a systemic lack of adherence to good manufacturing practices.
Open in Dashboard
ID · 3e48e10b-d9ec-463f-a2bc-238f0af3f5d1